ABcomm, Inc., with headquarters in Champaign, Illinois and Scottsdale, Arizona, has been involved in developing continuing education and training programs for health professionals since 1988.
Our primary focus is on accredited activities for physicians, pharmacists and nurse practitioners. ABcomm, Inc. is accredited by the American Council for Continuing Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Academy of Nurse Practitioners (AANP).
ABcomm, Inc.
November 1, 2008
This half-day Minifellowship is designed to provide physicians with evidence-based information on current issues and management strategies in the treatment of HIV/AIDS. Through a live patient interview, lectures, case studies and open discussions, the small group format facilitates interaction between attendees and local and national opinion leaders.
CME Sponsor: ABcomm, Inc.
Course Directors/Instructors:
Edwin DeJesus, MD; Sara Henn, MD; Theo Hodge,
MD
Registration Fee: $30
Number of credits:
5.5 AMA PRA Category 1 Credits™
Registration:
By Fax: Fax
completed form to ABcomm at (217) 355 – 1469
By Phone:
Call ABcomm at (800) 451 - 4068
Detailed Description:
This half-day Minifellowship is designed to provide physicians with evidence-based information on current issues and management strategies in the treatment of HIV/AIDS. Through a live patient interview, lectures, case studies and open discussions, the small group format facilitates interaction between attendees and local and national opinion leaders. The goal of this Minifellowship is to enhance the knowledge of providers resulting in improved patient care. Topics have been selected based on extensive needs assessment data in the treatment of HIV/AIDS, including past participant surveys, clinical expert input, and practice guideline reviews.
Learning Objectives:
- Discuss significant developments in the clinical course and management of HIV/AIDS with special focus on antiretroviral therapy treatment regimens.
- Describe recent antiretroviral toxicity, resistance, drug interaction and side effect data, and strategies for management.
- Consider the impact of hepatitis co-infections and describe the most recent hepatitis treatment strategies.
- Demonstrate knowledge of the variable effects on insulin resistance, diabetes, and cardiovascular risks associated with different classes of antiretroviral therapy.
- Describe the physical and psychological impact of HAART related lipodystrophy on long-term patient compliance to treatment.